Craft

Kangstem Biotech

Stock Price

₩2.1 K

2024-10-29

Market Capitalization

₩114.9 B

2024-10-29

Revenue

₩7.7 B

FY, 2024

Kangstem Biotech Summary

Company Summary

Overview
Kangstem Biotech (강스템바이오텍) is a biopharmaceutical company that focuses on blood-derived stem cell therapy. It develops therapeutic products for patients suffering from rare and incurable diseases using umbilical cord blood-derived stem cells. Additionally, the company provides the technology to isolate the non hematological system stem cell with multi conversion and high purity from the cord blood.
Type
Public
Status
Active
Founded
2010
HQ
KR | view all locations
Website
http://www.kangstem.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Seoul HQ

    Korea (Republic of)

    943-19 Daechi-dong, Gangnam-gu

Kangstem Biotech Financials

Summary Financials

Revenue (Q3, 2025)
₩2.5B
Gross profit (Q3, 2025)
₩2.4B
Net income (Q3, 2025)
(₩14.2B)
Cash (Q3, 2025)
₩4.8B
EBIT (Q3, 2025)
(₩14.0B)
Enterprise value
$118.3B

Footer menu